CEO research orientation, organizational context, and innovation in the pharmaceutical industry

Nino van de Wal, Christophe Boone, Victor Gilsing, Bob Walrave

Onderzoeksoutput: Bijdrage aan tijdschriftTijdschriftartikelAcademicpeer review

11 Downloads (Pure)

Samenvatting

This study develops and tests a comprehensive framework that explains what, when, and how CEO characteristics influence firms’ innovation outcomes in R&D-intensive industries. Empirical evidence from 109 CEOs from 87 U.S.-based pharmaceutical firms over the period 2001–2013 reveals that research-oriented CEOs – those with ability and motivation for science and technology – increase their firms’ innovation outcomes. The results indicate that the CEO–innovation relationship strongly depends on the extent of CEOs’ managerial discretion, which is shaped by the organizational context. We contribute to a more comprehensive understanding of the role of CEOs in firms´ innovation performance differentials.

Originele taal-2Engels
Pagina's (van-tot)239-254
Aantal pagina's16
TijdschriftR and D Management
Volume50
Nummer van het tijdschrift2
Vroegere onlinedatum16 okt 2019
DOI's
StatusGepubliceerd - mrt 2020

Vingerafdruk Duik in de onderzoeksthema's van 'CEO research orientation, organizational context, and innovation in the pharmaceutical industry'. Samen vormen ze een unieke vingerafdruk.

  • Citeer dit